Improvement of walking ability in patients with adrenoleukodystrophy treated with fampridine as compassionate use

Neurologia (Engl Ed). 2021 Jun;36(5):393-395. doi: 10.1016/j.nrleng.2020.07.018. Epub 2021 Mar 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • 4-Aminopyridine
  • Adrenoleukodystrophy* / drug therapy
  • Compassionate Use Trials*
  • Humans
  • Potassium Channel Blockers / therapeutic use
  • Walking

Substances

  • Potassium Channel Blockers
  • 4-Aminopyridine